229678AH0
Cubist Pharmaceuticals Inc
Could not find a ticker for this position, may be a filing error
A biopharmaceutical company that made medicines for serious bacterial infections, best known for the hospital antibiotic Cubicin, used to treat drug-resistant infections like MRSA. Founded in 1992 in Lexington, Massachusetts, its name was a play on its flagship drug rather than a nod to the Picasso art movement. Cubicin's chemistry traces back to a soil microbe found on Mount Ararat in Turkey, and the company was absorbed by Merck in 2015.
CONVERTIBLEUnderlying: CBSTCUSIP: 229678AH0HealthcareUS1 derivative reporter
1.875% Convertible Senior Notes due 2020 — Acquired by Merck in 2015